Will you regain weight after stopping Mounjaro or Wegovy?
Some weight regain is common after stopping Mounjaro or Wegovy. It does not happen to everyone in the same way, and it does not mean you will automatically return to your starting weight. The pattern seen in clinical trials is clear, though: when GLP-1 or GIP/GLP-1 treatment is stopped, weight often starts to move back upwards unless there is a strong maintenance plan in place. [5][6][7]
That is because these medicines are not only 'willpower aids'. Mounjaro contains tirzepatide and works through GIP and GLP-1 pathways. Wegovy contains semaglutide and works through GLP-1 pathways. Both affect appetite, fullness, cravings, and food intake while they are being used. The UK patient leaflets for both medicines describe their role in helping people feel fuller, less hungry, and less driven by cravings, alongside diet and physical activity. [1][3]
When the medicine is stopped, those appetite effects gradually reduce. At the same time, a smaller body usually needs fewer calories than it did before weight loss. That combination - more hunger plus lower energy needs - is one reason maintenance can feel harder than the active weight loss phase.
What the clinical trials show about weight regain
The most useful evidence comes from withdrawal and extension studies. These do not predict exactly what will happen to one person, but they show the direction of risk when treatment is stopped.
|
Medicine / evidence
|
Key finding after stopping
|
What this means
|
|
Mounjaro / tirzepatide - SURMOUNT-4
|
After a 36-week tirzepatide lead-in, people switched to placebo gained 14.0% from week 36 to week 88. Those continuing tirzepatide lost a further 5.5%. [5]
|
Stopping after successful treatment led to substantial regain in the trial group.
|
|
Wegovy / semaglutide - STEP 1 extension
|
After semaglutide 2.4 mg and structured lifestyle intervention stopped, participants regained 11.6 percentage points by week 120, about two-thirds of prior loss. [6]
|
Regain was common within the year after withdrawal.
|
|
Weight-management medicines overall - 2026 BMJ review
|
Weight regain after stopping averaged around 0.4 kg/month overall, with faster regain reported for newer medicines such as semaglutide and tirzepatide. [7]
|
Long-term maintenance needs ongoing support, not only a short course of medicine.
|
Is there a Mounjaro rebound effect?
'Mounjaro rebound' is a useful search phrase because it describes what many patients worry about: appetite returning, weight rising, or previous eating patterns becoming harder to manage. Clinically, it is better to avoid treating rebound as a mysterious reaction. The more accurate explanation is that the medicine's appetite effect fades, while the body's usual weight-regain biology remains active.
Some people notice hunger, cravings, or food noise returning before weight changes on the scale. That does not mean they have failed. It is a signal to tighten the maintenance plan and speak to the prescriber if the change is hard to manage.
This is also why the answer is not simply 'eat less and exercise more'. Those behaviours matter, but the appetite shift is biological. A good maintenance plan gives the person structure before the strongest hunger signals return.
Can you just stop taking Mounjaro or Wegovy?
Do not stop Mounjaro or Wegovy without talking to your doctor, pharmacist, nurse, or prescriber. The UK patient leaflets for both medicines advise people not to stop without speaking to a healthcare professional. [1][3]
This matters for three reasons. First, if you have type 2 diabetes or take medicines such as insulin or a sulfonylurea, stopping or changing treatment may affect blood glucose planning. Second, a planned break is not the same as a missed dose. The patient leaflets give specific missed-dose rules, but a longer break or restart should be handled by your prescriber. Third, restarting at an unsuitable dose after a break may increase side-effect risk.
There is no standard UK product-leaflet tapering schedule that proves tapering prevents weight regain. Some clinicians may use a step-down or individualised plan, but this should be a prescribing decision, not something to improvise yourself.
Safety check before stopping, pausing, or restarting
Stopping, pausing, or restarting prescription weight-loss medicine is a clinical decision. Use this as a safety check, not as personal dosing advice.
|
Situation
|
Why it matters
|
What to do
|
|
You want to stop, pause, restart, or take a break
|
Dose timing, tolerability, blood glucose risk, and restart dose may need review.
|
Speak to your prescriber before changing treatment. Do not restart from an old dose without advice. [1][3]
|
|
You miss one Mounjaro dose
|
The Mounjaro leaflet gives specific missed-dose instructions, but this is not the same as a planned break.
|
If it is 4 days or less, use it when remembered; if more than 4 days, skip it. Do not double dose. Minimum time between doses is 3 days. [1]
|
|
You miss one Wegovy dose
|
The Wegovy leaflet gives specific missed-dose instructions.
|
If it is 5 days or less, use it when remembered; if more than 5 days, skip it. Do not double dose. [3]
|
|
Severe, persistent stomach pain, with or without nausea or vomiting
|
This can be a warning sign of acute pancreatitis, which is serious.
|
Stop using the medicine and seek urgent medical help. [1][3]
|
|
Repeated vomiting or diarrhoea, dizziness, or difficulty keeping fluids down
|
Fluid loss can cause dehydration and may affect kidney function, especially if you already have kidney problems.
|
Contact your prescriber or seek medical advice promptly; urgent care may be needed if symptoms are severe. [1][3]
|
|
Planning pregnancy, pregnant, or breastfeeding
|
Mounjaro and Wegovy have medicine-specific pregnancy and breastfeeding warnings, including planned stopping windows.
|
Speak to your prescriber before trying to conceive, and contact them straight away if pregnancy occurs while using treatment. [1][2][3][4]
|
How long do Mounjaro and Wegovy stay in your system?
Mounjaro and Wegovy do not vanish from the body the day you miss or stop an injection. Tirzepatide has an elimination half-life of about 5 days. Semaglutide has an elimination half-life of about 1 week and may remain in the circulation for several weeks after the last 2.4 mg dose. [2][4]
This helps explain why some people do not feel an immediate change after stopping. Appetite may return gradually rather than overnight. The important point is to plan for the weeks and months after the final dose, not only the first few days.
Why weight regain can happen even when your habits have improved
People often assume weight regain means the habits they built during treatment were not real. That is too simplistic. Mounjaro and Wegovy can make it easier to practise smaller portions, leave food, reduce snacking, and tolerate longer gaps between meals. When the medicine is removed, the same habits may need more structure because the appetite support is no longer doing as much of the work.
Weight loss also changes the maths of maintenance. A person who is lighter usually burns fewer calories day to day than they did at their starting weight. This means the food intake that caused weight loss earlier may later become a maintenance intake, and the food intake that once maintained weight may now be too high. That is one reason weight maintenance deserves its own plan rather than being treated as the end of treatment.
The useful question is not, 'Have I failed?' It is, 'What has changed?' A four-to-six-week trend is usually more informative than one difficult week. Look for appetite changes, reduced protein, more liquid calories, fewer steps, weaker sleep, lower resistance training, increased alcohol, or stress patterns that make eating less structured.
What to agree before your final dose of Mounjaro or Wegovy
Before stopping, agree the practical details with your prescriber. This does not need to be complicated, but it should be specific enough that you know what to do if appetite, cravings, side effects, or weight regain become difficult to manage.
- Why you are stopping: side effects, cost, supply, pregnancy planning, treatment completion, or another reason
- The intended timing: a short pause, a planned stop, or a review before deciding
- How you will monitor weight: for example, a weekly average rather than reacting to daily fluctuations
- What should trigger contact: rapid regain, difficult hunger, persistent vomiting or diarrhoea, severe abdominal pain, or blood glucose concerns if relevant
- What happens after a missed dose or longer break: do not treat leaflet missed-dose rules as a restart plan after a prolonged pause
- Whether other medicines need review: especially diabetes medicines, blood pressure medicines, or any treatment affected by weight loss or reduced food intake
This plan is particularly important if you are considering restarting later. Restarting from an old dose, using a leftover pen, or copying a previous schedule can create avoidable risk. Your prescriber can decide whether restarting, changing medicine, continuing lifestyle support, or using a longer-term maintenance approach is more appropriate.
How to keep weight off after stopping Mounjaro or Wegovy
The maintenance plan should start before the medicine is stopped. NICE says all weight-management medicines should be used alongside a reduced-calorie diet and increased physical activity, and that people stopping weight-management medicines should be offered support to help maintain weight loss. [8]
A realistic plan usually includes:
A food structure you can repeat: regular meals, enough protein, high-fibre foods, and fewer high-calorie snack gaps
- Resistance exercise: strength work helps protect muscle and function during and after weight loss
- Cardiovascular activity: NHS guidance for adults recommends at least 150 minutes of moderate activity each week, or 75 minutes of vigorous activity, plus strengthening activities on at least 2 days a week [9]
- Weight monitoring without panic: regular weighing can catch regain early, but daily fluctuations should not drive rushed decisions
- A hunger plan: agree what to do if appetite, cravings, or night-time eating return
- Clinical follow-up: review weight, side effects, blood glucose risk if relevant, and whether medication should be continued, paused, restarted, or changed
The plan should be practical rather than punitive. Maintenance is not about proving you can manage without support. It is about replacing some of the medicine's appetite structure with food, activity, monitoring, and clinical support that can survive normal life.
What if you regain weight after stopping?
If weight starts to return, respond early rather than waiting until you feel you have 'undone' the treatment. A small regain is easier to manage than a large one, and it gives your prescriber more options.
Useful next steps include checking whether hunger has increased, whether your meal structure has changed, whether activity has dropped, whether sleep or stress has worsened, and whether there are medical factors affecting weight. Your prescriber may discuss continued lifestyle support, restarting medication, changing medicine, or a longer-term maintenance approach. Do not restart an old pen or return to a previous dose without clinical advice.
